AbCellera Biologics Inc. (8QQ.F)
Discovers and develops antibody-based medicines for diseases with few treatment options.
4.70+0.01%Healthcare
StockGlow Score
Neutral
BearishBullish
1 year ago+30.6%
The outlook
AbCellera trades near the lower end of its 52-week range at $4.70, sitting 43% of the way between its low and high. Price action is mixed relative to its moving averages, suggesting neither clear upward nor downward momentum. Analyst coverage appears thin, and the overall sentiment leans neutral.
What’s behind the score
Price trendMixed vs its moving averages
52-week range43% of the way from its 52-week low to high
Market cap
$1.44B
52-wk high
7.65
52-wk low
2.49
50-day avg
5.25
200-day avg
3.79
Trailing P/E
—